August 14, 2026

Updated ASTRO Guideline Reflects a New Era for Radiation Therapy in Pancreatic Cancer

An updated clinical practice guideline from the American Society for Radiation Oncology substantially expands and modernizes recommendations for the use of radiation therapy in pancreatic cancer.

Baptist Health South Florida

August 07, 2026

Roswell Park Only Hospital in Region Offering SBRT for Prostate Cancer

Roswell Park Comprehensive Cancer Center is now offering an innovative approach to treating prostate cancer that provides a more efficient course of radiation therapy and incorporating a spacer to help shield the rectum from unnecessary treatment.

Roswell Park Comprehensive Cancer Center

August 07, 2026

Adrenal Tumor Patients Need the Multidisciplinary Care Roswell Park Provides

Adrenal cortical carcinomas are rare, diagnosed in only one or two people per million annually, but are also more likely to be found at a later state because they are largely asymptomatic.

Roswell Park Comprehensive Cancer Center

August 04, 2026

U.S. News & World Report Names Dana-Farber Brigham Cancer Center #1 Locally, #3 Nationally for 2026-2027

Dana-Farber Brigham Cancer Center has been recognized as the Best Hospital for Cancer in Massachusetts and ranked #3 in the nation by U.S. News & World Report. This is the 26th consecutive year Dana-Farber Brigham has been recognized for its excellence in caring for people with cancer.

Dana-Farber

August 01, 2026

Dana-Farber Research News 08.01.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from July 1 - 15.

Dana-Farber

July 31, 2026

Lung Cancer Care in 2026: Earlier Detection, Earlier Intervention, More Individualized Treatment

Lung cancer care is entering a more precise and increasingly proactive era. While the disease remains a leading cause of cancer mortality, earlier detection through low-dose CT screening, broader use of molecular profiling and rapid advances in targeted therapy and immunotherapy are changing how patients are diagnosed, staged and treated.

Baptist Health South Florida

July 16, 2026

Dana-Farber Researchers Identify CDK8 as a Potential Therapeutic Target for Alveolar Rhabdomyosarcoma

Dana-Farber Cancer Institute researchers studied alveolar rhabdomyosarcoma (aRMS), an aggressive childhood cancer with poor survival and few targeted treatment options, to identify new treatment vulnerabilities. Using a network-based analysis of large functional genomic datasets, they found that aRMS cells depend on CDK8, a protein involved in controlling gene activity.

Dana-Farber

July 09, 2026

In the United States, Men May Be More Likely Than Women to Receive Later-Stage Diagnoses for Many Cancer Types

Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States.

The ASCO Post

July 09, 2026

In the United States, Men May Be More Likely Than Women to Receive Later-Stage Diagnoses for Many Cancer Types

Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States.

The ASCO Post

July 08, 2026

Surgical Manual from Roswell Park Created to Advance Bladder Cancer Surgery Worldwide

Roswell Park Comprehensive Cancer Center announces the release of a new operative surgical manual authored by Khurshid Guru, MD.

Roswell Park Comprehensive Cancer Center